135 results on '"Secq, Véronique"'
Search Results
2. Angiographic and histopathological study on bronchial-to-pulmonary vascular anastomoses on explants from patients with cystic fibrosis after bronchial artery embolisation
3. Novel partial loss-of-function variants in the tyrosyl-tRNA synthetase 1 (YARS1) gene involved in multisystem disease
4. Diagnostic des thymomes et carcinomes thymiques malpighiens ; expérience du réseau RYTHMIC
5. AB004. Basaloid carcinoma of the thymus: experience of the RYTHMIC network over an 8-year period
6. Figure S5 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
7. Data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
8. Supplementary data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
9. Transcriptomic Analysis Predicts Survival and Sensitivity to Anticancer Drugs of Patients with a Pancreatic Adenocarcinoma
10. Rythmic-Pathologie : le groupe français de relecture des tumeurs épithéliales thymiques du réseau clinique Rythmic
11. Transplanted lungs and the “white plague”: A case-report and review of the literature
12. Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation
13. Évaluation immunohistochimique du risque métastasique dans les cancers du sein débutants sur microbiopsies
14. Homotypic cell cannibalism, a cell‐death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer
15. Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study
16. Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer
17. Validation of an immunohistochemical signature predictive of 8-year outcome for patients with breast carcinoma
18. Léiomyomatose œsophagienne diffuse et syndrome d’Alport : rapport d’un cas
19. A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays
20. Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAFV600E mutation study from the French national cohort
21. Neutrophil extracellular traps are associated with the pathogenesis of diffuse alveolar hemorrhage in murine lupus
22. Complex Compound Inheritance of Lethal Lung Developmental Disorders Due to Disruption of the TBX-FGF Pathway
23. Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts
24. Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid
25. LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
26. BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
27. Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness
28. PAP/HIP protein is an obesogenic factor
29. Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation)
30. Fatal acute respiratory distress syndrome with diffuse alveolar damage: donor lymphocyte infusion imputability?
31. Correction: Rapid Diagnosis of Lung Tumors, a Feasability Study Using Maldi-Tof Mass Spectrometry
32. Rapid Diagnosis of Lung Tumors, a Feasability Study Using Maldi-Tof Mass Spectrometry
33. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes
34. Regional molecular genetics centers in thoracic oncology: what and who should be tested?
35. Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches
36. Abstract B06: Impact of intratumoral microenvironment and epithelial cells crosstalk in pancreatic carcinogenesis
37. Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation
38. Novel therapeutic targets for pancreatic adenocarcinoma revealed by a multi-omics analysis of patient-derived xenografts
39. Prognostic factors of response to adjuvant chemotherapy after curative resection for pancreatic ductal adenocarcinoma: Prognostic impact of CDA, predictive value of DPD for 5FU efficiency, and hENT1 for gemcitabine.
40. Plateformes de biologie moléculaire en oncologie thoracique : quelles recherches, pour qui ?
41. Novel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs
42. Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarrays
43. Pure Spindle Cell Follicular Carcinoma of the Thyroid
44. Des bagues à chaton bien trompeuses…
45. Transcriptome analysis predicts clinical outcome and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma
46. BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC).
47. BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
48. [Thymoma and squamous thymic carcinoma diagnosis; experience from the RYTHMIC network].
49. Childhood pulmonary Langerhans cell histiocytosis: a comprehensive clinical-histopathological and BRAF V600E mutation study from the French national cohort.
50. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.